Patent · US Active

Nilotinib HCl crystalline forms

US8227477B2 · kind B2 · utility

11Cited by
1References
28Claims
0Family size

Inventors

Key dates

Filing dateNov 5, 2009
Grant dateJul 24, 2012
Priority date—
Expiry dateAug 25, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Crystalline forms of Nilotinib HCl are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.